Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP)

Radiology

Volumn 200, Issue 1, 1996, Pages 69-77

  Murakami, Takamichi ^a   Baron, Richard L ^a   Peterson, Mark S ^a   Oliver III, James H ^a   Davis, Peter L ^a   Confer, Scharmen R ^a   Federle, Michael P ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Liver neoplasms, diagnosis, 761.12143, 761.323; Liver neoplasms, MR, 761.12143; Magnetic resonance (MR), contrast enhancement, 761.12143; Manganese

Indexed keywords

CONTRAST MEDIUM; MANGAFODIPIR;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CONFIDENCE INTERVALS; CONTRAST MEDIA; EDETIC ACID; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE; MIDDLE AGED; PYRIDOXAL PHOSPHATE;

EID: 0029994023     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.200.1.8657947     Document Type: Article

References (16)

1. Hamm B, Vogl TJ, Branding G, et al. Focal liver lesions: MR imaging with Mn-DPDP-initial clinical results in 40 patients. Radiology 1992; 182:167-174.
2. Bernardino ME, Young SW, Lee JK, Weinreb JC. Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity. Radiology 1992; 183:53-58.
3. Rofsky NM, Weinreb JC, Bernardino ME, Young SW, Lee JK, Noz ME. Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging. Radiology 1993; 188:53-59.
4. Vogl TJ, Hamm B, Schnell B, et al. MnDPDP enhancement patterns of hepatocellular lesions on MR images. JMRI 1993; 3:51-58.
5. Liou J, Lee JKT, Borrello JA, Brown JJ. Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images. Magn Reson Imaging 1994; 12:71-79.
6. Rocklage SM, Carheris WP, Quay SC, Hahn FE, Raymond KN. Manganese (II) N,N′-dipyridoxylethylenediamine-N,N′-diacetate 5,5′-bis(phosphate): synthesis and characterization of a paramagnetic chelate for magnetic resonance imaging enhancement. Inorg Chem 1989; 28:477-485.
7. Bernardino ME, Young SW, Lee JKT, Weinreb JC. Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease, Invest Radiol 1991; 26:S148-S149.
8. Elizondo G, Fretz CJ, Stark DD, et al. Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 1991; 178:73-78.
9. Lim KO, Stark DD, Leese PT, Pfefferbaum A, Rocklage SM, Quay SC. Hepatobiliary MR imaging: first human experience with MnDPDP. Radiology 1991; 178:79-82.
10. Young SW, Simpson BB, Ratner AV, Matkin C, Carter EA. MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate. Magn Reson Med 1989; 10:1-13.
11. Rummeny E, Ehrenheim Ch, Gehl HB, et al. Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors: results of clinical phase II trials in Germany including 141 patients. Invest Radiol 1991; 26:S142-S145.
12. Murakami T, Baron RL, Federle MP, et al. Cirrhosis of the liver: MR imaging with Mangafodipir Trisodium (MnDPDP). Radiology 1996; 198:567-572.
13. Sidhu MK, Muller HH, Aggeler J, Johes AL, Young SW. Manganese dipyridoxal diphosphate-enhanced magnetic resonance imaging in the evaluation of hepatocyte function. Invest Radiol 1993; 28:903-910.
14. Wendt RE III, Wilcott MR III, Nitz W, Murphy PH, Bryan RN. MR imaging of susceptibility-induced magnetic field inhomogeneities. Radiology 1988; 168:837-841.
15. Hacke EM, Tkach JA, Parrish TB. Reduction of T2* dephasing in gradient fieldecho imaging. Radiology 1989; 170:457-462.
16. Miller WJ, Baron RL, Dodd GD III, Federle MP. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 1994; 193:645-650.